Revenue growth has accelerated to 152.9% in 2026Q1, though operating margins remain deeply negative at -23.4% due to substantial fixed-cost burdens.
| Sales/Revenue | 90.26M | 73.01M | 24.17M | 8.79M | 4.41M | 2.77M | 4.68M |
| Revenue Growth % | 172.57% | 202.11% | 174.91% | 99.39% | 59.05% | -40.76% | - |
| Cost of Goods Sold | 73.9M | 64.75M | 42.5M | 23.73M | 9.85M | 7.1M | 6.7M |
| COGS % of Revenue | - | 88.68% | 175.85% | 269.92% | 223.36% | 256.17% | 143.09% |
| Gross Profit | 16.36M | 8.26M | -18.33M | -14.94M | -5.44M | -4.33M | -2.02M |
| Gross Margin % | 18.13% | 11.32% | -75.85% | -169.92% | -123.36% | -156.17% | -43.09% |
| Gross Profit Growth % | - | 145.08% | -22.71% | -174.65% | -25.64% | -114.73% | - |
| Operating Expenses | 37.5M | 54.91M | 26.07M | 23.77M | 12.6M | 6.29M | 5.43M |
| OpEx % of Revenue | - | 75.21% | 107.87% | 270.4% | 285.82% | 227.06% | 116.11% |
| Selling, General & Admin | 26.28M | 22.96M | 18.73M | 20.36M | 10.57M | 4.84M | 4.1M |
| SG&A % of Revenue | - | 31.44% | 77.49% | 231.56% | 239.78% | 174.75% | 87.69% |
| Research & Development | 11.23M | 9.43M | 7.34M | 3.68M | 2.03M | 1.45M | 1.33M |
| R&D % of Revenue | - | 12.92% | 30.39% | 41.83% | 46.04% | 52.31% | 28.42% |
| Other Operating Expenses | 0 | 22.52M | 0 | -262K | 0 | 0 | 0 |
| Operating Income | -21.14M | -46.65M | -44.4M | -38.71M | -18.04M | -10.62M | -7.45M |
| Operating Margin % | -23.42% | -63.89% | -183.72% | -440.33% | -409.19% | -383.23% | -159.2% |
| Operating Income Growth % | - | -5.06% | -14.7% | -114.56% | -69.83% | -42.61% | - |
| EBITDA | -17.71M | -42.28M | -39.35M | -36.9M | -15.95M | -9.18M | -6.21M |
| EBITDA Margin % | -19.63% | -57.91% | -162.81% | -419.78% | -361.67% | -331.24% | -132.78% |
| EBITDA Growth % | 54.31% | -7.46% | -6.62% | -131.42% | -73.67% | -47.79% | - |
| D&A (Non-Cash Add-back) | 3.42M | 4.37M | 5.05M | 1.81M | 2.1M | 1.44M | 1.24M |
| EBIT | -21.14M | -46.65M | -44.4M | -38.71M | -17.33M | -9.9M | -7.41M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | -5K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 5K |
| Other Income/Expense | -18.56M | 2.62M | -271K | 1.93M | 709K | 727K | 31K |
| Pretax Income | -39.7M | -44.02M | -44.67M | -36.78M | -17.33M | -9.9M | -7.42M |
| Pretax Margin % | -43.98% | -60.3% | -184.84% | -418.34% | -393.11% | -357% | -158.54% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -39.7M | -44.02M | -44.67M | -36.78M | -17.33M | -9.9M | -7.42M |
| Net Margin % | -43.98% | -60.3% | -184.84% | -418.34% | -393.11% | -357% | -158.54% |
| Net Income Growth % | 10.09% | 1.45% | -21.47% | -112.19% | -75.14% | -33.41% | - |
| Net Income (Continuing) | -39.7M | -44.02M | -44.67M | -36.78M | -17.33M | -9.9M | -7.42M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.29 | -0.35 | -0.45 | -0.43 | -0.20 | -0.10 | -0.07 |
| EPS Growth % | 25.24% | 22.22% | -4.65% | -115% | -104.5% | -32.34% | - |
| EPS (Basic) | - | -0.35 | -0.45 | -0.43 | -0.20 | -0.10 | -0.07 |
| Diluted Shares Outstanding | 136.95M | 124.64M | 101.87M | 86.2M | 84.61M | 100.99M | 100.99M |
| Basic Shares Outstanding | 136.95M | 124.64M | 101.87M | 86.2M | 84.61M | 100.99M | 100.99M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
Manufacturing yield and scale risk
As reported in recent quarterly filings, Amprius Technologies achieved a significant revenue acceleration, with top-line figures reaching $28.5 million in 2026Q1, representing a substantial increase from the $2.3 million reported in 2024Q1, driven primarily by project-based purchase orders within the specialized aerospace and UAV sectors.
The triple-digit growth trajectory suggests a successful transition from early-stage R&D contracts to more meaningful commercial-scale deliveries. However, investors should monitor whether this momentum is sustainable or if it reflects the lumpy nature of defense-related procurement cycles that may not repeat in subsequent periods.
Based on the provided financial data, Amprius's gross margin has fluctuated significantly, moving from a deep negative of -195.2% in 2024Q2 to a positive 20.1% by 2026Q1, indicating the inherent challenges of stabilizing manufacturing yields for their proprietary silicon nanowire anode technology.
The recent improvement in gross margin suggests that the company is beginning to overcome initial production hurdles, though the volatility implies that the cost structure remains highly sensitive to throughput levels. Future margin expansion appears contingent on the company's ability to transition from batch-based processing to more efficient, continuous manufacturing formats.
According to the income statement, Amprius continues to face significant operating losses, with operating margins remaining deeply negative at -23.4% in 2026Q1, despite the substantial revenue growth observed over the last ten quarters, highlighting the heavy fixed-cost burden of their current industrial footprint.
The lack of meaningful operating leverage suggests that the company's current revenue scale is insufficient to cover the high R&D and facility-related expenses required for their specialized manufacturing. Analysts should investigate whether the planned Colorado expansion will provide the necessary scale to achieve operating break-even or if it will further exacerbate the current cash burn.
As indicated by the financial statements, Amprius maintains a high cost structure characterized by persistent R&D and SG&A expenses, which collectively continue to outpace gross profit generation, resulting in a net loss of $5.0 million in the most recent quarter.
The company's expense discipline appears focused on maintaining technical leadership rather than immediate profitability, which is typical for firms in the pre-commercialization phase of battery technology. Investors should remain cautious regarding the sustainability of this spending, as the company's reliance on equity markets for funding may necessitate a more conservative approach to capital allocation.
While the 202% revenue growth is impressive, a critical analysis suggests that Amprius may be trapped in a permanent niche, as the high cost of CVD-grown nanowires may limit adoption to price-insensitive aerospace applications, potentially capping the total addressable market for their current technology.
Short-term revenue gains could mask long-term structural limitations, particularly if the company fails to achieve the manufacturing throughput required for broader automotive or consumer electronics markets. The reliance on a narrow customer base in the defense sector warrants further investigation into the durability of these contracts and the potential for margin compression if competitive alternatives emerge.
Quick answers to the most common questions about buying AMPX stock.
For fiscal year 2025, Amprius Technologies, Inc. (AMPX) reported total revenue of $73.0M. This represents a 1460.4% increase compared to $4.7M in 2020.
Amprius Technologies, Inc. (AMPX) reported a net loss of $44.0M for the fiscal year ending 2025.
Amprius Technologies, Inc. (AMPX) reported an operating income of $-46.6M, resulting in an operating profit margin of -63.9%. This margin reflects the operational efficiency of the business before interest and taxes.
Amprius Technologies, Inc. (AMPX) generated $8.3M in gross profit for the year, representing a gross profit margin of 11.3%. This demonstrates the company's core pricing power and production efficiency.